Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Therapeutic Advances in Medical Oncology|November 3, 2025
Macrocytosis as a risk factor for secondary esophageal cancer in hypopharyngeal cancer patients: a multicenter case-control studyChing-Nung Wu, Po-Teng Chiang, Chung-Yi Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2021
Definitive chemoradiotherapy for clinical T4b esophageal cancer - Treatment outcomes, failure patterns, and prognostic factorsTzu-Ting Huang, Shau-Hsuan Li, Yen-Hao Chen, et al.
BMC Cancer|August 22, 2018
The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapyYen-Hao Chen, Hung-I Lu, Chien-Ming Lo, et al.
Annals of Transplantation|December 15, 2015
Incidentally Small Pulmonary Nodule in Candidates for Living Donor Liver TransplantationYi-Ju Wu, Chih-Che Lin, Yu-Hung Lin, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 26, 2014
Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinomaYen-Hao Chen, Cheng-Hua Huang, Hung-I Lu, et al.
Annals of Transplantation|October 20, 2018
Clinical Outcomes of Tuberculosis in Recipients After Living Donor Liver TransplantationNoruel Gerard A Salvador, Sin-Yong Wee, Chih-Che Lin, et al.
Oncotarget|August 27, 2016
Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activationShau-Hsuan Li, Hung-I Lu, Alice Y W Chang, et al.
Life (Basel, Switzerland)|May 28, 2022
The Impact of Weight Loss during Chemoradiotherapy for Unresectable Esophageal Cancer: Real-World ResultsTzu-Ting Huang, Shang-Yu Chou, Yun-Hsuan Lin, et al.
Journal of Translational Medicine|December 16, 2014
Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in ratsSarah Chua, Fan-Yen Lee, Tzu-Hsien Tsai, et al.
Surgery|March 2, 2015
Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinomaShau-Hsuan Li, Chang-Han Chen, Hung-I Lu, et al.
Pageof 12